Management of Regenics AS 2021

Karl R. Bryn, Chief Executive Officer (Dec. 1st 2021)

Karl R. Bryn will initiate his assignment with the company on December 1st 2021. Karl is an MD from NTNU, Trondheim, and comes to Regenics from the role of Director of Digital & Business Development at Aleris Helse, Norway. Previously Karl served as a consultant for McKinsey & Company, working with growth and portfolio strategy across industries, including within healthcare regulatory and external affairs. Karl also has several years of clinical experience as a medical doctor.


Karin Gilljam, Chief Scientific Officer

Karin is a PhD coming to Regenics AS from a Postdoc position at the University of Oslo, Department of Molecular Medicine. She has an extensive academic background in biochemistry, molecular medicine, immunology and cancer. Previously she held a Postdoc position at NTNU Trondheim, Department of Cancer Research and Molecular Medicine. Karin is responsible for overall scientific oversight and quality at Regenics, and coordinates the Horizon 2020 3D AquaHeal EU commision project.


Mitchell Jones, Patent Attorney (US), JD PhD

Dr. Mitchell Jones is in charge of Regenics AS patents, trademarks and IP strategy since 2010. Dr. Jones is a founding shareholder of Casimir Jones S.C., Madison, Wisconsin, US. Dr. Jones recieved his Juris Doctor in 1997 from Vanderbilt University, and a PhD. in Endocrinology - Reproductive Physiology in 1994 from the University of Tennessee. Dr. Jones has extensive experience in obtaining, litigating and licensing patents with special emphasis on patents in life science disciplines, and has obtained hundreds of patents worldwide for clients. Dr. Jones has experience in representing US and international companies, from start-ups to Fortune 500 companies, as well as leading United States universities. Dr. Jones works for Regenics AS in a consulting role.


Markus Heldrup, Researcher

Markus Heldrup joined Regenics in 2014. He has a BSc degree in Biochemistry from the University of Oslo. Markus is now a researcher and device developer at Regenics. Markus also oversees production, analysis and quality control at the Company's Research and production site at Regenics Labs, Storo, Oslo, Norway.





Contacts management:

Karl R. Bryn, CEO

mobile +47 92809390


Karin Gilljam, Chief Scientific Officer

mobile +47 91809887


Mitchell Jones, Patent Attorney

mobile +1 608 6621277